The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL, marketed by International Medication Systems.
Phytonadione Injectable Emulsion is used to treat hypoprothrombinaemia caused by vitamin K deficiency or interference. It is also indicated for the prophylaxis and treatment of vitamin K deficiency bleeding in neonates. For detailed indications, refer to the product label.
According to IQVIA, the estimated market size for Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL single-dose prefilled syringes, is approximately US$44 million for the twelve months ending June 2025.
Alembic Pharmaceuticals is a vertically integrated research-driven company that manufactures and markets generic medicines globally.
The company's consolidated net profit jumped 14.6% to Rs 154.38 crore while revenue from operations grew 9.54% to Rs 1,710.72 crore in Q1 June 2025 over Q1 June 2024.
Shares of Alembic Pharmaceuticals shed 0.35% to Rs 943.95 on the BSE.
"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."